Panbela Therapeutics, Inc. (PBLA)
OTCMKTS: PBLA · Delayed Price · USD
0.420
-0.070 (-14.20%)
Apr 19, 2024, 3:51 PM EDT - Market closed
Panbela Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.58 | 1.29 | 11.87 | 9.02 | 2.45 | 1.41 | 0.15 | 0.44 | 0.93 | 0.16 | Upgrade
|
| Cash & Cash Equivalents | 2.58 | 1.29 | 11.87 | 9.02 | 2.45 | 1.41 | 0.15 | 0.44 | 0.93 | 0.16 | Upgrade
|
| Cash Growth | 100.62% | -89.17% | 31.53% | 268.40% | 74.31% | 824.34% | -65.30% | -52.65% | 464.81% | 178.42% | Upgrade
|
| Receivables | 0.18 | 0.05 | 0.32 | 0.32 | 0.36 | 0.33 | 0.42 | 0.32 | 0.73 | 0.23 | Upgrade
|
| Other Current Assets | 0.3 | 0.44 | 0.09 | 0.41 | 0.28 | 0.11 | 0.2 | 0.12 | 0.07 | 0 | Upgrade
|
| Total Current Assets | 3.06 | 1.78 | 12.28 | 9.76 | 3.09 | 1.85 | 0.77 | 0.88 | 1.73 | 0.39 | Upgrade
|
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | Upgrade
|
| Other Long-Term Assets | 8.74 | 3.2 | 0.59 | 0.06 | 0.05 | 0.05 | 0 | 0 | 0.08 | 0 | Upgrade
|
| Total Long-Term Assets | 8.74 | 3.2 | 0.59 | 0.06 | 0.05 | 0.05 | 0 | 0 | 0.08 | 0.02 | Upgrade
|
| Total Assets | 11.8 | 4.98 | 12.87 | 9.81 | 3.14 | 1.9 | 0.77 | 0.88 | 1.81 | 0.41 | Upgrade
|
| Accounts Payable | 9.94 | 2.87 | 0.64 | 0.55 | 0.6 | 1.06 | 1.2 | 1.25 | 0.59 | 0 | Upgrade
|
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | -0.35 | -1.54 | -3.28 | -0.25 | 0.02 | Upgrade
|
| Current Debt | 1 | 1.65 | 0 | 0 | 0.12 | 0.35 | 1.54 | 3.28 | 0.25 | 0.57 | Upgrade
|
| Other Current Liabilities | 1.38 | 3.32 | 2.02 | 0.81 | 1.05 | 0.57 | 2.97 | 4.27 | 0.79 | 0.02 | Upgrade
|
| Total Current Liabilities | 12.32 | 7.83 | 2.66 | 1.37 | 1.76 | 1.63 | 4.17 | 5.52 | 1.38 | 0.62 | Upgrade
|
| Long-Term Debt | 4.19 | 5.19 | 0 | 0 | 0 | 0 | 0.29 | 0 | 3.08 | 0 | Upgrade
|
| Other Long-Term Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | Upgrade
|
| Total Long-Term Liabilities | 4.19 | 5.19 | 0 | 0 | 0 | 0 | 0.29 | 0 | 3.11 | 0 | Upgrade
|
| Total Liabilities | 16.51 | 13.03 | 2.66 | 1.37 | 1.76 | 1.63 | 4.46 | 5.52 | 4.49 | 0.62 | Upgrade
|
| Total Debt | 5.19 | 6.84 | 0 | 0 | 0.12 | 0.35 | 1.83 | 3.28 | 3.33 | 0.58 | Upgrade
|
| Debt Growth | -24.11% | - | - | - | -66.86% | -80.82% | -44.31% | -1.44% | 476.49% | -0.85% | Upgrade
|
| Common Stock | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.03 | 0.03 | 0 | Upgrade
|
| Retained Earnings | -125.5 | -91.09 | -56.16 | -46.03 | -41.26 | -35.06 | -29.15 | -18.78 | -13.67 | -13.99 | Upgrade
|
| Comprehensive Income | 0.75 | 0.76 | 0.13 | -0.38 | 0.31 | 0.28 | -0.17 | 0.08 | 0.01 | -0.11 | Upgrade
|
| Shareholders' Equity | -4.71 | -8.05 | 10.21 | 8.45 | 1.39 | 0.27 | -3.69 | -4.64 | -2.68 | -0.21 | Upgrade
|
| Total Liabilities and Equity | 11.8 | 4.98 | 12.87 | 9.81 | 3.14 | 1.9 | 0.77 | 0.88 | 1.81 | 0.41 | Upgrade
|
| Net Cash / Debt | -2.62 | -5.56 | 11.87 | 9.02 | 2.33 | 1.06 | -1.67 | -2.84 | -2.4 | -0.41 | Upgrade
|
| Net Cash / Debt Growth | - | - | 31.53% | 286.71% | 121.14% | - | - | - | - | - | Upgrade
|
| Net Cash Per Share | -24068.23 | -6484.45 | 24323.78 | 28000.94 | 9822.62 | 271.56 | -563.11 | -1096.56 | -2047.78 | -3441.63 | Upgrade
|
| Working Capital | -9.26 | -6.06 | 9.62 | 8.39 | 1.33 | 0.22 | -3.4 | -4.64 | 0.36 | -0.22 | Upgrade
|
| Book Value Per Share | -43333.85 | -9388.98 | 20931.53 | 26219.46 | 5831.26 | 68.98 | -1241.67 | -1792.97 | -2287.54 | -1757.99 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.